2-(p-Nitrofenil)-4-izopropilmorfin
| |
| Nazivi | |
|---|---|
| IUPAC naziv
(1S,5R,13R,14S,17R)-10-(2,4-dinitrofenoksi)-4-metil-12-oksa-4-azapentaciklo [9.6.1.01,13.05,17.07,18]oktadeka-7(18),8,10,15-tetraen-14-ol
| |
| Drugi nazivi
7,8-Didehidro-3-α-(2',4'- dinitro)fenoksi-4,5-α-epoksi-17-metilmorfinan-6-α-ol
| |
| Identifikacija | |
3D model (Jmol)
|
|
| ChemSpider | |
| |
| Svojstva | |
| C23H21N3O7 | |
| Molarna masa | 451,43 g/mol |
Ukoliko nije drugačije napomenuto, podaci se odnose na standardno stanje materijala (na 25 °C [77 °F], 100 kPa). | |
 verifikuj (šta je   ?)
| |
| Reference infokutije | |
2,4-Dinitrofenilmorfin je analog morfina u kome je hidroksilna grupa supstituisana sa dinitro fenoksi grupom.[3][4]
Reference
[уреди | уреди извор]- ^ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today. 15 (23-24): 1052—7. PMID 20970519. doi:10.1016/j.drudis.2010.10.003.
- ^ Evan E. Bolton; Yanli Wang; Paul A. Thiessen; Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry. 4: 217—241. doi:10.1016/S1574-1400(08)00012-1.
- ^ Eddy, N. B.; Sumwalt, M. (1939). „Studies of Morphine, Codeine, and Their Derivatives. XV. 2,4-Dinitrophenylmorphine” (pdf). Journal of Pharmacology and Experimental Therapeutics. 67 (2): 127—141.
- ^ Huggins, R. A.; Bryan, A. R. (1951). „Some cardiovascular actions of dinitrophenylmorphine hydrochloride”. Texas Reports on Biology and Medicine. 9 (2): 314—318. PMID 14835466.